Saltar al contenido
Merck

387A

Kit de fosfatasa de ácido leucocitaria (TRAP)

Kit formulated with all liquid reagents

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

En este momento no podemos mostrarle ni los precios ni la disponibilidad

Acerca de este artículo

UNSPSC Code:
12352106
NACRES:
NA.47
eCl@ss:
42010102

Saltar a

Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

Quality Level

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

dilution

(for histology)

application(s)

hematology
histology

shipped in

wet ice

storage temp.

2-8°C

¿Está buscando productos similares? Visita Guía de comparación de productos

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo
386A86C86R
application(s)

hematology
histology

application(s)

hematology
histology

application(s)

hematology
histology

application(s)

hematology
histology

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

Quality Level

500

Quality Level

500

Quality Level

500

Quality Level

500

shelf life

Expiry date on the label.

shelf life

Expiry date on the label.

shelf life

Expiry date on the label.

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

IVD

for in vitro diagnostic use

IVD

for in vitro diagnostic use

IVD

for in vitro diagnostic use

alkaline phosphatase diagnosis, inflammatory markers, baff, ctx, osteo calcin, pinp, ntx, acid phosphatase staining,

-

-

-

Biochem/physiol Actions

Las preparaciones de sangre periférica o de médula ósea se fijan en un portaobjetos para microscopio. La película resultante se incuba en una disolución de ácido fosfórico naftol AS-BI y de GBC Fast Garnet recién diazotizado. El kit se utiliza para demostrar la presencia de fosfatasa ácida y de fosfatasa ácida resistente al tartrato (TRAP) en preparaciones sanguíneas, de médula ósea y tejidos.

Solo componentes del kit

Referencia del producto
Descripción

  • Hematoxylin Solution, Gill No. 3 (kit only) 50 mL

Los componentes del kit también están disponibles por separado

Referencia del producto
Descripción
SDS

  • 3863Acetate Solution, 2.5 M, pH 5.2 50 mLSDS

  • 915Citrate Solution, pH 3.6±0.1 (25 °C), 27 mM 50 mLSDS

  • 3872Fast Garnet GBC Base Solution 10 mLSDS

  • 3871Naphthol AS-BI Phosphoric Acid Solution 10 mLSDS

  • 914Sodium nitrite solution 10 mLSDS

  • 3873Tartrate Solution 10 mLSDS

Related product

Referencia del producto
Descripción
Precios

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1B - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - STOT RE 2 Oral

target_organs

Kidney

Clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

L Wei et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 25(8), 2089-2096 (2014-05-09)
Recently, the use of the pharmacological agent strontium ranelate has come to prominence for the treatment of osteoporosis. While much investigation is focused on preventing disease progression, here we fabricate strontium-containing scaffolds and show that they enhance bone defect healing
Yun Zhang et al.
Biological & pharmaceutical bulletin, 39(12), 2028-2035 (2016-12-03)
Osteolysis induced by chronic Gram-negative bacterial infection underlies many bone diseases such as osteomyelitis, septic arthritis, and periodontitis. Drugs that inhibit lipopolysaccharide (LPS)-induced osteolysis are critically needed for the prevention of bone destruction in infective bone diseases. In this study
Jihai Wang et al.
Frontiers in pharmacology, 9, 64-64 (2018-02-24)
Lipopolysaccharide (LPS) can induce bone loss by stimulating bone resorption. Natural compounds have great potential for the treatment of osteolytic bone diseases. Magnesium lithospermate B (MLB) plays an important role in protecting against oxidative damage and also has potential anti-inflammatory
Isabella Azario et al.
Scientific reports, 7(1), 9473-9473 (2017-08-27)
Umbilical cord blood (UCB) is a promising source of stem cells to use in early haematopoietic stem cell transplantation (HSCT) approaches for several genetic diseases that can be diagnosed at birth. Mucopolysaccharidosis type I (MPS-I) is a progressive multi-system disorder caused
Yu Wang et al.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 47(6), 2291-2306 (2018-07-06)
Osteoporosis is a commonly occurring condition marked by a loss of bone density. Previous evidence has highlighted the roles played by microRNAs as potential treatment tools for the disease. At present, the influence of long non-coding RNAs (lncRNAs) on the

Número de artículo de comercio global

SKUGTIN
387A-1KT04061831967975

Preguntas

1–10 de 14 Preguntas  
  1. Why does the kit procedure call for staining duplicate slides Beaker A and Beaker B?

    1 respuesta
    1. Beaker A stains all isoforms of Acid Phosphatase, while Beaker B stains only the Tartrate Resistant Acid Phosphatase (TRAP) isoenzyme of Acid Phosphatase. Beaker A serves as a control and it is recommended to run both Beaker A and Beaker B. Running only Beaker B makes it impossible to determine if the kit is working properly, whether the enzyme is present, or if the procedure was performed properly.

      If staining is present with slides for Beaker B, staining should also be present for the slides stained in Beaker A. However, if only Beaker B is utilized and no staining is present, the problem could be with the kit, the specimen, or how the procedure was performed. Therefore, Beaker A should always be run.

      ¿Le ha resultado útil?

  2. Is there a staining protocol available for culturing cells using either the 386A or 387A kits for blood smears?

    1 respuesta
    1. The 387A kit does not have a published protocol for staining cultured cells. The kit is approved for human In Vitro Diagnostic Use and was primarily intended for detecting TRAP positive cells in peripheral blood or bone marrow, particularly for the detection of TRAP positive cells associated with Hairy Cell Leukemia. However, the procedure included with the kit can be used.

      First, remove the media, rinse briefly in isotonic PBS or suitable cell culture media, and then air dry the cells. Once dried, the cells can be fixed onto chamber slides, microtiter plates, or culture flasks. After fixing, the cells are washed.

      The procedure mentions staining slides for Beaker A and Beaker B. When staining cultured cells, think of staining duplicate wells.
      One set of cells will be incubated in the presence of tartrate (Beaker B), and the second set will be incubated without tartrate (Beaker A), which serves as the positive control.

      Staining cells without tartrate is essential for ensuring the kit is performing to expectations. The kit was designed to stain an equal number of slides/wells with and without tartrate, and there is a separate product number (387-3) for the tartrate reagent, which may be ordered separately.

      The kit instructions call for preparing a specific volume of staining reagent for Beaker A and Beaker B. If needed, the volume of reagent can be scaled down, but once prepared, the staining solution is for one-time use only and cannot be stored for later use.

      ¿Le ha resultado útil?

  3. Can a paraffin section be utilized as a positive control for the TRAP 386A or 387A procedures?

    1 respuesta
    1. Paraffin sections are not ideal controls for use with either the 386A or 387A TRAP kits. When sections are cut from a bone, the bone must first be fixed, then decalcified in EDTA, and finally, paraffin embedded. While the Tartrate Resistant Acid Phosphatase (TRAP) enzyme is relatively hardy, it may not always survive decalcification and paraffin processing. The most effective method of decalcification involves removing calcium with EDTA solutions. Harsh acids such as HCL, Sulfuric Acid, and Formic Acid typically deactivate the TRAP enzyme, isoenzyme 5.

      Suitable controls recommended for use with the kit are either peripheral blood smears or buccal smears. It is not known if buccal smears from animals are TRAP positive.
      With a peripheral blood smear, Beaker A slides should be positive, and Beaker B slides should be negative.
      With a buccal smear, both Beaker A and Beaker B slides should be positive.
      If peripheral blood smears or buccal smears are negative for both Beaker A or Beaker B, there may be a problem with the kit or possibly with the staining technique.

      In such cases, it is advisable to contact Technical Service for troubleshooting or to file a complaint.

      ¿Le ha resultado útil?

  4. I will perform TRAP staining to detect osteoclasts. Which mixture should I use for this, beaker A or beaker B?

    1 respuesta
    1. When staining osteoclasts, both Beaker A and Beaker B are recommended. Beaker A will stain all 7 different isoenzymes of Acid Phosphatase. No tartrate is added to the staining solution for Beaker A. Beaker B includes tartrate. The only cells that will stain in the presence of tartrate are the hairy cells of hairy cell leukemia and differentiated osteoclasts (isoenzyme 5). The remaining cells are inhibited by the presence of tartrate and will not display positive staining.
      Please see the link below to review the protocol for this kit:
      https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/539/315/387.pdf

      ¿Le ha resultado útil?

  5. Is the Leukocyte Acid Phosphatase TRAP kit compatible with paraffin sections that have been decalcified?

    1 respuesta
    1. The 386A and 387A kits are approved for In Vitro Diagnostic Use on peripheral blood smears and bone marrow smears. However, there are no claims for these kits working on paraffin sections, and they are not intended or approved for use with human bone.

      ¿Le ha resultado útil?

  6. Can the TRAP enzyme still be demonstrated after fixing mouse brain and soft tissue in 10% formalin and decalcifying in 10% EDTA for 4 weeks? Or was the length of time spent in 10% EDTA excessive, resulting in the deactivation of the TRAP enzyme?

    1 respuesta
    1. It is uncertain whether 4 weeks in 10% EDTA is too much time for decalcification. The most accurate methods for checking whether decalcification is complete typically involve using an X-ray or a chemical endpoint determination for the removal of calcium.

      ¿Le ha resultado útil?

  7. How can I easily prepare a TRAP positive control for use with Product 387A, Acid Phosphatase, Leukocyte (TRAP) Kit?

    1 respuesta
    1. A buccal smear from the inside of the human cheek makes an excellent positive control.  The epithelioid cells are TRAP positive.

      ¿Le ha resultado útil?

  8. Are results from Product 387A, Acid Phosphatase, Leukocyte (TRAP) Kit, qualitative or quantitative?

    1 respuesta
    1. The kit results are qualitative.  A microscope is used to determine the presence or absence of staining within the cytoplasm of the cell.

      ¿Le ha resultado útil?

  9. Are paraffin-embedded tissue sections suitable for use with Product 387A, Acid Phosphatase, Leukocyte (TRAP) Kit?

    1 respuesta
    1. The kit has been shown to work well with blood smears and cultured cells.  Whether the kit will work on paraffin sections depends upon the size of the bone, the decalcification (decal) agent used, and the paraffin processing schedule utilized.  In general the smaller the bone fragment and the more mild the decal, the more likely the kit would work. EDTA for short periods of time seems to be the only acceptable decal agent.  As the bone sections become larger and the time in the decal becomes longer, the less likely it becomes that the kit will provide positive results.

      ¿Le ha resultado útil?

  10. What is the Department of Transportation shipping information for this product?

    1 respuesta
    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      ¿Le ha resultado útil?

1–10 de 14 Preguntas  

Revisiones

Sin puntuación

Filtros activos

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico